7 results
Warfarin and DOAC Pharmacology
Warfarin - Dabigatran - Rivaroxaban - Apixaban - Edoxaban
Target - Prodrug - Bioavailability
Warfarin and DOAC Pharmacology ... Rivaroxaban - Apixaban ... Plasma Protein Binding ... #NOAC #comparison ... #table #dabigatran
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Xa inhibitors - Apixaban ... anticoagulation #pharmacology ... medications #doac #comparison ... #table #management
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
New Potassium-Binding ... #Potassium #Binding ... #KBinders #Kayexelate ... #Comparison #Table ... #Pharmacology #
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
Table 22 provides ... various phosphate-binding ... #Pharmacology #Nephrology ... Phosphate #Phosphorus #Binders ... #Comparison #Table
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
that directly binds ... that inhibits factor ... Xa by binding to ... #Pharmacology #Pathophysiology ... DOAC #Dabigatran #Apixaban
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... aspiration #Potassium #Binding ... #medications #pharmacology ... #table #comparison ... #binders
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
activity, high binding ... the sublingual tablet ... formulation. ... Pharmacokinetics #Comparison ... #Table #Pharmacology